News
CellFree Sciences, MOU Signed With CALICI
CellFree Sciences-CALICI, Innovative Drug Development - Treatment Research MOU Signed
Accelerating Synergy in Innovative Drug Development between Korea and Japan
CALICI, a protein structure-based AI drug discovery (SBDD) company headquartered in the US and Korea, and CellFree Sciences (CFS), a Japanese company based in Yokohama known for its wheat germ cell-free protein expression technology and MaZiQ arrayTM system (an array of unmodified human genomic protein beads), recently signed an agreement and formalized their partnership.
This partnership aims to make breakthrough progress in the development of treatments for infectious diseases, metabolic disorders, and cancer through in silico and experimental protein interaction research, target validation/off-target analysis, and mechanism of action research by combining CALICI's expertise in AI modeling and drug candidate optimization with CFS's services for analyzing intermolecular interactions and proteomics profiling.
The two companies will act as mutual agencies for each other's services in Korea and Japan, and will promote cross-border collaboration and provide smooth customer access to innovative technologies. The two companies also began a non-public joint research.
“CFS's MaZiQ array® will validate the results of AI-designed drug candidates and add meaning to experimental success, and through this, our partnership will be able to provide new drug development companies with higher value-added services,” said CFS CEO Ozawa Satoshi.
Dr. Jae Moon Choi, CEO of CALICI, said, “This partnership symbolizes a new era of drug development, and aims to create synergies by combining the unique technologies of both companies to develop more efficient new drugs and treatments for diseases.” He added, “I expect that the two companies will be able to provide breakthrough solutions to both countries faster and more efficiently together.”
Meanwhile, CALICI was selected as the 6th Daejeon company for IBK Changgo, an innovative startup company development program run by IBK.
We, CellFree Sciences.Co., Ltd. be @ 20th The Korean Society of Nonclinical Study
We are joining the exhibition of 『20th The Korean Society of Nonclinical Study Worshop』 in Gyeongju of Korea.
Dates: October 17th (The) - 18th (Fri.), 2024, 10:00 - 17:00
Venue: LAHAN Select Hotel in Gyeongju .
We Join this exhibition for the aim of customer acquisition of collaboration between CALICI Co which which has an advanced platform (Pharmaco-Net) that combines AI-based compound design with the calculation of KD values, and we, CellFree Sciences, which supplies the assay service by MaZiQ arrayTM for TPD drug discovery, Protac, transcription factors and so on.
We, CellFree Sciences.Co., Ltd. be @ BioJapan 2024
CellFree Sciences will be at 『BioJapan 2024』 in Yokohama from October 9th to 11th.
Dates: October 9 (Wed.) - 11 (Fri.), 2024, 10:00 - 17:00
Venue: Pacifico Yokohama Exhibition Hall
1-1-1 Minato Mirai, Nishi-ku, Yokohama, Kanagawa 220-0012, Japan
●Booth No.: A-36 / Ehime University (Protein Island Matsuyama)
We will introduce the following products and services
(1) Reagents and kits for wheat cell-free protein synthesis system and contract services
(2) Molecular interaction analysis service
●Booth No.: B-25 in Yokohama/Kawasaki Pavilion
Cooperative booth with CALICI Co., a U.S. company that provides unique AI based Drug Design service.
We will also introduce our Molecular Interaction Analysis Service using our arrays.
We also plan to hold a seminar on 10/10(Thu.).
Time: 11:30-12:00
Place: Presentation Stage B
Speaker: Professor Tatsuya Sawasaki, Center for Proteoscience, Ehime University
Lecture Title: “Proximity-dependent biotin labeling of interacting proteins using AirID
We look forward to seeing you there and to your registration for online partnering.
Revised manual for "ProteoLiposome BD Kit" was uploaded.
Revised manual for "ProteoLiposome BD Kit" was uploaded , now.
The content of the method for Rehydration of lyophilized Liposomes has been revised.
CellFree Sciences Co., Ltd.
The last day of Exhibition for IUPAB2024 in KYOTO, today.
The IUPAB 2024 exhibition is finally on its last day, today.
We would like to thank so much everyone who has dropped at our booth so far,
and we look forward to seeing you all at booth No. 30 today .
CellFree Sciences Co., Ltd.
We, CellFree Sciences.Co. Ltd. be @IUPAB in KYOTO
CellFree Sciences will be at 『21st IUPAB Congress 2024 (IUPAB2024)』 in KYOTO from June 24th to 28th.
We will introduce technologies, products and services related to membrane protein synthesis using the Wheat germ Cell-Free expression system, with a particular focus on the recently launched NanoDisc synthesis.
We sincerely look forward to seeing you at our booth No30.
CellFree Sciences Co., Ltd.
We, CellFree Sciences.Co., Ltd. be @ DRUG DISCOVERY CHEMISTRY in SanDiego
CellFree Sciences will be at 『19th DRUG DISCOVERY CHEMISTRY』 in SanDiego from April 1st to 4th.
We will introduce our “Protein Beads Array technology” at the poster session (Poster # P-19) as follows.
Welcome to our Poster place and discuss with us for novel E3 Ligase hunting, Genome wide On/Off target detection, and so on.
CellFree_Sciences_CF-PPiD_Technology_Poster.pdf
Product information on Wheat germ CellFree Protein "Dialysis Synthesis" kit is now available.
Product information for Wheat germ CellFree Protein Dialysis Synthesis Kit (WEPRO7240 Series Dialysis Core Kit) is now available.
- WEPRO7240 Dialysis Kit (p/n CFS-D7)
- WEPRO7240G Dialysis Kit (p/n CFS-D7G)
- WEPRO7240H Dialysis Kit (p/n CFS-D7H)
These kits are ideal for scale-up synthesis of Wheat germ CellFree protein synthesis in larger quantities and with higher efficiency.
Now on Launching : NanoDisc BD Kit
We, CellFree Sciences Co., Ltd. launched "NanoDisc BD Kit", now !!
This new kit has following features ;
- WEPRO7240ND, a wheat germ extract optimized for Nanodisc synthesis
- With the Bi-Layer & Dialysis (BD) reaction, which has a proven track record in proteoliposome synthesis
- A new method for NanoDisc synthesis (patent pending) that co-expresses mRNA for MSP protein and mRNA for the target membrane protein.
This kit enables high-quality and high-efficiency synthesis of NanoDisc for membrane proteins that have been difficult to
express in the past, and is hoped to further advance research on functional and structural analysis.
=====================Product Information ==============================
-Catalogue Number : CFS-CNDE-BD
-Product Name NanoDisc BD Kit
-SIZE : 5 reaction with 2.0 mL reaction scales of Bi-layer & Dialysis (BD) reaction
-Stock Temperature : -80℃
-List Price : $4,000.- /kit
-Specification : Claudin 4 can be synthesized as NanoDisc with more than 100ug per
Bi-Layer & Dialysis reaction.
====================================================================
Please contact to us and to our sales agents in your region, now.
Campaign "Launching for NanoDisc BD Kit" !!
Campaign !!
“launching for NanoDisc BD Kit”
Now, we are offering a 25% off campaign for try to use NanoDisc BD Kit until the end of this December.
$4,000/kit to $3,000/ kit !!
And also, if you try Wheat germ Cell Free Protein expression system for the fist time…………
with the purchase of the NanoDisc BD kit, you will receive a free Premium PLUS Expression Kit to confirm of your target membrane proteins expression.
Please contact to us and to our sales agents in your region, now.
